These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10380064)

  • 1. Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
    Bergquist PA; Hunke WA; Reed RA; Manas D; Forsyth RJ; Kenney RR; Cook J; Holahan M
    J Clin Pharm Ther; 1999 Apr; 24(2):125-32. PubMed ID: 10380064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
    Bergquist PA; Manas D; Hunke WA; Reed RA
    Am J Health Syst Pharm; 2001 Jul; 58(13):1218-23. PubMed ID: 11449879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
    Kupie TC; Trusley C; Ben M; Trissel LA
    Am J Health Syst Pharm; 2008 Sep; 65(18):1735-59. PubMed ID: 18769000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
    Patel K; Hursting MJ
    Am J Health Syst Pharm; 2005 Jul; 62(13):1381-4. PubMed ID: 15972381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
    Schaaf LJ; Tremel LC; Wulf BG; Vernon KK
    J Clin Pharm Ther; 1990 Oct; 15(5):371-6. PubMed ID: 1963175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
    Sattler A; Jage J; Krämer I
    Pharmazie; 1998 Jun; 53(6):386-91. PubMed ID: 9675768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of doripenem with other drugs during simulated Y-site administration.
    Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D
    Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days.
    Garabito MJ; Jimenez L; Bautista FJ; Santos-Rubio MD; Perez-Rodrigo I
    Am J Health Syst Pharm; 2001 Oct; 58(19):1850-1. PubMed ID: 11596703
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drug additives.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Plitz GW; Cutie AJ
    Am J Hosp Pharm; 1982 Jun; 39(6):1013-5. PubMed ID: 7102682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and compatibility of anakinra with intravenous cimetidine hydrochloride or famotidine in 0.9% sodium chloride injection.
    Nahata MC; Morosco RS; Sabados BK; Weber TR
    J Clin Pharm Ther; 1995 Apr; 20(2):97-9. PubMed ID: 7650081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
    Floy BJ; Royko CG; Fleitman JS
    Am J Hosp Pharm; 1990 May; 47(5):1097-100. PubMed ID: 2337102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs.
    Mayron D; Gennaro AR
    Am J Health Syst Pharm; 1996 Feb; 53(3):294-304. PubMed ID: 8808027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry.
    Pereira-Rosario R; Utamura T; Perrin JH
    Am J Hosp Pharm; 1988 Jun; 45(6):1350-2. PubMed ID: 3414704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
    Lam XM; Ward CA; du Mée CP
    Am J Health Syst Pharm; 1995 Sep; 52(17):1904-9. PubMed ID: 8528854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intropin (dopamine hydrochloride) intravenous admixture compatibility, Part 3: stability with miscellaneous additives.
    Gardella LA; Kesler H; Amann A; Carter JE
    Am J Hosp Pharm; 1978 May; 35(5):581-4. PubMed ID: 655182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs.
    Keyi X; Gagnon N; Bisson C; Desmarais M; LeBel M
    Ann Pharmacother; 1993 Apr; 27(4):422-6. PubMed ID: 8477115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.